Clinical Trials Sponsored by Yvonne Romero

Total 1192 results

Yvonne Romero
Bausch Health Americas, Inc.

Completed

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

Erosive Esophagitis

United States
Yvonne Colgrove, PT, PhD

Completed

The Effect of Yoga in Chronic Low Back Pain

Low Back Pain

United States
Philipps University Marburg Medical Center
Gaia AG; Prof. Dr. Yvonne Nestoriuc

Terminated

Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes (ONSIDE)

Diabetes Mellitus Type 2

Germany
Dionne Peacher

Withdrawn

Individualized vs Low PEEP in One Lung Ventilation

Lung Diseases | Obesity | One-Lung Ventilation

United States
Charlotte Sonne
Psychiatric Center Ballerup

Completed

The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy (PTF3)

Depression | Post Traumatic Stress Disorder

Denmark
Germans Trias i Pujol Hospital
Pau Romera Romero; Jorge Loscos Arenas; Nevena Romanic Bubalo; Jordi Castellví...

Unknown

Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy

Open Angle Glaucoma | Choroidal Thickness | Non Penetrating Deep Sclerectomy

Spain
iGluco
Luis Gabriel Luque Romero

Recruiting

Study of GLUCUBE Performance, a Non-invasive System for Monitoring Blood Glucose Levels Based on Near Infrared Spectroscopy (NIRS) Technology. (GLUCUBE)

Blood Glucose

Spain
Yvonne Efebera
Bristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...

Terminated

Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Omeros Corporation

Recruiting

Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

Ukraine
Omeros Corporation

Recruiting

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Thrombotic Microangiopathies | Hematopoietic Stem Cell Transplantation

United States, Germany, Israel, Netherlands, Spain
Omeros Corporation

Completed

Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects

Schizophrenia

United States
Omeros Corporation

Terminated

Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

Intraocular Lens Replacement | Intraoperative Floppy Iris Syndrome

Austria, Germany
Omeros Corporation

Completed

Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.

Cataract Extraction

United States
Omeros Corporation

Completed

Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

Urinary Calculi | Renal Calculi | Kidney Stones | Urinary Stones | Urinary Tract Stones

United States
Omeros Corporation

Completed

Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solution in Subjects Undergoing Meniscectomy (C07-004)

Postoperative Pain

United States
Omeros Corporation

Completed

Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction

Anterior Cruciate Ligament Reconstruction

United States
Omeros Corporation

Terminated

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

IgA Nephropathy

United States, Argentina, Australia, Belgium, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, India, Italy, Korea, Republic of, Lithuania, Poland, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, United Kingdom
Omeros Corporation

Completed

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

Thrombotic Microangiopathies

United States, Belgium, Bulgaria, Hong Kong, Italy, Lithuania, Malaysia, New Zealand, Poland, Singapore, Taiwan, Thailand
Omeros Corporation

Unknown

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Lupus Nephritis | IgAN | C3 Glomerulopathy | MN

United States, Hong Kong
Omeros Corporation

Terminated

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Huntington's Disease

United States
Omeros Corporation

Completed

Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification (OMS302-ILR-004)

Intraocular Lens Replacement

United States, Netherlands
Omeros Corporation

Completed

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Urinary Calculi | Urinary Stones | Urinary Tract Stones

United States
Julieta María Méndez Romero

Completed

Antibacterial Effect of the Infusion of Green Tea Used as a Mouthwash on Saliva and Bacterial Plaque

Dental Plaque

Paraguay
Julieta María Méndez Romero

Completed

Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans

Dental Plaque | Streptococcus, Other Specified Group

Paraguay
Omeros Corporation

Recruiting

Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

Switzerland, Germany, Ukraine, United Kingdom
Omeros Corporation

Recruiting

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

C3 Glomerulopathy | Idiopathic Immune Complex-Mediated Glomerulonephritis

Lithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
Omeros Corporation

Recruiting

Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab

Paroxysmal Nocturnal Hemoglobinuria

Germany, Greece, Switzerland, United Kingdom
Omeros Corporation

Completed

A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement (ILR7)

Congenital Cataract | Unilateral Cataract Extraction

United States
Omeros Corporation

Completed

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

Meniscal Tear

United States
Omeros Corporation

Unknown

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Thrombotic Microangiopathies | Atypical Hemolytic Uremic Syndrome

United States
Omeros Corporation

Completed

Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

Cataract

United States
Omeros Corporation

Completed

Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification (OMS302-ILR-003)

Intraocular Lens Replacement

United States
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Eleuterio Atanasio Sánchez Romero

Recruiting

Efficacy of Mobilization With Movement on Conditioned Pain Modulation in Chronic Low Back Pain Patients

Chronic Low-back Pain

Spain
Roberto Rotundo
Geistlich Pharma AG

Completed

Adjunctive Benefit of a Xenogenic Collagen Matrix

Gingival Recession
Rogers Behavioral Health

Recruiting

Pilot Study of CBT With tDCS for Adults Being Treated for Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Romark Laboratories L.C.

Not yet recruiting

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

COVID-19
Romark Laboratories L.C.

Recruiting

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Rhinovirus | Enterovirus

United States
Romark Laboratories L.C.

Completed

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

COVID-19

United States
Romark Laboratories L.C.

Active, not recruiting

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

COVID-19 | Viral Respiratory Illnesses

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Chronic Hepatitis B

Singapore
Romark Laboratories L.C.

Terminated

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

COVID-19 | Viral Respiratory Illnesses

United States
Romark Laboratories L.C.

Completed

Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Rhinovirus | Enterovirus

United States, Puerto Rico
Rogers Sciences Inc.

Unknown

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

Metastatic Breast Cancer

United States
Romark Laboratories L.C.

Completed

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Influenza

United States, Australia, Puerto Rico
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease

Clostridium Infections

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients (STEALTHC-3)

Chronic Hepatitis C

United States
Romark Laboratories L.C.

Terminated

Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease

Crohn's Disease

United States
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Rotavirus Infection | Norovirus Infection | Adenoviridae Infection

3

Subscribe